Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry

Although Hereditary Hemorrhagic Telangiectasia (HHT) is characterized by an overwhelming bleeding propensity, patients with this disease may also present medical conditions that require antithrombotic therapy (AT). However, precise information on indications, dosage, duration, effectiveness, and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaetani, Eleonora, Agostini, Fabiana, Giarretta, Igor, Porfidia, Angelo, Di Martino, Luigi, Gasbarrini, Antonio, Pola, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356769/
https://www.ncbi.nlm.nih.gov/pubmed/32498318
http://dx.doi.org/10.3390/jcm9061699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356769/
https://www.ncbi.nlm.nih.gov/pubmed/32498318
http://dx.doi.org/10.3390/jcm9061699

Ejemplares similares